General Information
BounceWatch is an independent company data service, not affiliated with Aptus Biotech. To contact Aptus Biotech, visit aptusbiotech.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Spain Market
Biotechnology
About Aptus Biotech
Taxonomy: Biotech Start-up, Aptamers, Therapeutic Tools, Diagnostic Tools, SELEX Method, Drug Discovery, Oligonucleotide, Biomedical Applications, Research and Development, Biotechnological Applications, Aptamer Selection, Chemical Synthesis, Biomedical Research, Innovative Technology, Ramon y Cajal Hospital Foundation
No funding data available for Aptus Biotech yet.
Aptus Biotech Alternatives & Competitors
Chemistry platform built on proprietary chiral chemical space, progressing hits to small molecule le...
Cutting-Edge Pharmacological Treatment for Obesity
Bristol-Myers Squibb acquired Flexus for $800M upfront & $450M in potential earnouts in 2015.
FAQ About Aptus Biotech
Source: BounceWatch company record for Aptus Biotech, https://bouncewatch.com/company/aptus-biotech, updated 28 October 2024. When citing, please name BounceWatch and link this page.